Medical Devices Industry and Market Prospects 2013-2023
Medical devices - your guide to developments, opportunities, and revenues
What does the future hold for medical devices? Visiongain's report shows you potential revenues to 2023, assessing data, trends, opportunities and prospects in this market.
Our study gives you revenue forecasts to 2023 at overall world market and national level. There you see financial results, interviews, trends, opportunities, and revenue predictions. You also gain 64 figures, 57 tables and three interviews with authorities in the industry.
Prospects for leading countries shown to 2023
Regulatory, demographic and commercial developments worldwide will influence the market, especially fast-rising demand in emerging markets.
Our analyses show you individual revenue forecasts to 2023 for 11 national markets:
Germany, France, UK, Italy and Spain (EU5 nations)
BRIC nations - Brazil, Russia, India, and China
Many commercial opportunities exist in developed and developing countries. Our study explains, assessing progress and prospects.
There you assess the medical device industry's future - hear about developments and find their significance.
Companies and overall 2017 market value - what predicted revenue?
Our report predicts the world market for medical devices will reach $398bn in 2017 and expand further to 2023.
Our work shows you which technologies and organisations hold greatest potential.
In particular, you explore these organisations:
Johnson and Johnson
Becton, Dickinson & Co.
In general, a company profile gives you the following information:
Discussion of a company's activities and outlook
Recent financial results
Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations
Medical device revenue forecasts to 2023
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for submarkets and products
In addition to analyses of the overall world market, you see revenue forecasting for two important medical device submarkets:
That investigation also discusses sectors within those submarkets. You discover revenue forecasts to 2023 for the following sectors:
The drug eluting stents market
Neuromodulation devices (including SCS, DBS and VNS markets).
See how and why those sectors can prosper. You see prospects for established and emerging technologies and competition.
Issues affecting the manufacturing and selling of medical devices
In addition, our report discusses issues and events affecting that industry and market from 2013, including these:
The medical device excise tax - hampering innovation?
Strong government support across major international markets - driving growth
Market driven by an aging population
Market susceptibility to economic pressures
International expansion - targeting emerging national markets
Comparative effectiveness research as an added expense
Large number of participating companies - increasing rivalry among competitors
You see disc ussions of technological, commercial and economic matters, with emphasis on organisations competing in the industry.
Ways Medical Devices Industry and Market Prospects 2013-2023 helps you
In summary, our report gives you the following knowledge:
Revenues to 2023 for the overall world market - discover that industry's prospects, finding promising areas for investments and revenues
Assess 11 leading companies, and others, discovering activities and outlooks
Market forecasting to 2023 for the US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), India, China, Brazil and Russia
Prospects for cardiology and neurology devices to 2023
Competition and opportunities - see what affects the medical devices industry, learning what shapes its future, esp. prospects for sustaining and developing business
Opinions from o ur survey, seeing interviews with industry authorities.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
An Aging Global Population
The over-65 age group is an important demographic group in the medical device industry. The
future fate of the medical device industry will be largely determined by whatever happens to the
people within this demographic. A large proportion of the products in the medical device market are
targeted at the over-65s. This is especially true for neurological and orthopaedic devices, where
many of the conditions treated using medical devices is most prevalent in the over-65s.
With reports estimating the global over 65 population to reach 1billion by 2030, the aging
population globally provides a strong opportunity to expand revenue base in a number of device
sectors. The UN estimates the global over-65 population to have tripled over the last 50 years. It
also estimates this number to increase by more than 50% in the next four decades to reach 418m
by 2050 in developed regions of the world. Moreover, the UN estimates that, in developing
countries, the over-65 population will reach 1.6bn by 2050, representing a third of the total
population in these countries.
Apnex Medical Inc
Association of Indian Medical Device Industry (AIMED)
Becton Dickinson & Co
Biotronik SE & Co
Brazilian National Agency for Sanitary Surveillance (ANVISA)
Bristol Myers Squibb
CeloNova BioSciences Inc
Center for Devices and Radiological Health (CDRH) [US]
Central Drug Standard Control Organisation (CDSCO) [India]
China Food and Drug Administration (CFDA)
ClearStream TechnologiesCochlear Ltd.
Conor Medsystems Inc
Economic Committee for Medical Products [France]
Ethicon Endo-Surgery Inc
European Commission (EC)
Food & Drug Administration (FDA) [US]
Gemeinsame Bundesausschuss (G-BA) [Germany]
Global Harmonisation Task Force (GHTF)
ImThera Medical Inc
Intelect Medical Inc
International Medical Device Regulators Forum (IMDRF)
International Neuromodulation Society (INS)
Johnson & Johnson (J&J)
JW Medical Systems
Kiestra Lab Automation
Lupin Pharmaceuticals Inc
Medison Co Ltd
Medical Device Regulatory Authority (MDRA) [India]
MiCell Technologies Inc
Ministry of Health, Labour, and Welfare (MHLW) [Japan]
MIV Therapeutics Inc
National Epilepsy Foundation [US]
National Institute for Health and Clinical Excellence (NICE) [UK]
Northstar Neuroscience Inc
Ortho-Clinical Diagnostics Inc
Patient-Centered Outcomes Research Institute (PCORI) [US]
Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
Servizio Sanitario Nazionale (SSN) [Italy]
Sistema Unico de Saude (SUS) [Brazil]
St Jude Medical
St. Michael's Hospital, Toronto, Canada
Terumo Medical Corporation
Teva Pharmaceutical Industries Ltd
Third Wave Technologies Inc
United Nations (UN)
United State Patent and Trademark Office (USPTO)
World Health Organisation (WHO)
Electronic Access - Single User Fulfilled By Publisher
Electronic Access - Departmental 1-5 Users
Electronic Access - Global Site License Fulfilled by Publisher